The aim of the present study was to determine whether PNPLA3 polymorphism is linked to the degree of hepatic steatosis and fibrosis in patients with HCV infection and whether PNPLA3 is related to fibrosis and steatosis evolution three monthspost-SVR. This evidence concerns the gene PNPLA3 and fatty liver disease.